Advanced oxidation of pharmaceuticals: Chemical analysis and biological assessment of degradation products

Critical Reviews in Environmental Science and Technology

Volumn 41, Issue 3, 2011, Pages 215-242

  De Witte, Bavo ^a   Van Langenhove, Herman ^a   Demeestere, Kristof ^a   Dewulf, Jo ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

advanced oxidation processes; biological assessment; chemical analysis; degradation products; pharmaceuticals

Indexed keywords

ADVANCED OXIDATION; ADVANCED OXIDATION PROCESSES; ANALYTICAL METHODOLOGY; ANALYTICAL TECHNIQUES; BIOLOGICAL ASSESSMENT; BIOLOGICAL EFFECTS; DEGRADATION PRODUCTS; IDENTIFICATION TOOLS; LITERATURE DATA; MICROPOLLUTANTS; PHARMACEUTICAL DEGRADATION PRODUCTS; PHARMACEUTICALS;

CHEMICAL ANALYSIS; CHEMICALS; DRUG PRODUCTS; OXIDATION; OXIDATION RESISTANCE; RATING;

DEGRADATION;

AMOXICILLIN; BEZAFIBRATE; BUSPIRONE; ESTROGEN;

ADVANCED TECHNOLOGY; BIODEGRADATION; BIOLOGICAL ANALYSIS; CHEMICAL ANALYSIS; DRUG; LITERATURE REVIEW; OXIDATION; PHYSICOCHEMICAL PROPERTY;

ANALYTIC METHOD; ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CHROMATOGRAPHY; DEGRADATION KINETICS; DRUG INDUSTRY; ELECTRON; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE; OXIDATION KINETICS; POLLUTANT; SPECTROSCOPY; TOXICITY TESTING; ULTRAVIOLET RADIATION;

EID: 79551616245     PISSN: 10643389     EISSN: 15476537     Source Type: Journal    
DOI: 10.1080/10643380902728698     Document Type: Article

References (88)

1. Heberer, T. (2002). Occurrence, fate and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 131, 5-17. (Pubitemid 34461906)
2. Hirsch, R., Ternes, T., Haberer, K., and Kratz, K. L. (1999). Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 225, 109-118.
3. Lacey, C., McMahon, G., Bones, J., Barron, L., Morrissey, A., and Tobin, J. M. (2008). An LC-MS method for the determination of pharmaceutical compounds in wastewater treatment plant influent and effluent samples. Talanta 75, 1089-1097.
4. Kanda, R., Griffin, P., James, H. A., and Fothergill, J. (2003). Pharmaceutical and personal care products in sewage treatment works. J. Environ. Monitor. 5, 823-830.
5. Jones, O. A. H., Voulvoulis, N., and Lester, J. N. (2007). The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment. Environ. Pollut. 145, 738-744.
6. Stumpf, M., Ternes, T. A., Wilken, R. D., Rodrigues, S. V., and Baumann, W. (1999). Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci. Total Environ. 225, 35-141.
7. Ternes, T. (1998). Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32, 3245-3260.
8. Vieno, N. M., Tuhkanen, T., and Kronberg, L. (2006). Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass spectrometry detection. J. Chromatogr. A 1134, 101-111.
9. Jones, O. A. H., Voulvoulis, N., and Lester, J. N. (2001). Human pharmaceuticals in the aquatic environment: A review. Environ. Technol. 22, 1383-1394.
10. Jørgensen, S. E., and Halling-Sørensen, B. (2000). Drugs in the environment. Chemosphere 40, 691-699.
11. Barceló, D., and Petrovic, M. (2007). Pharmaceuticals and personal care products (PPCPs) in the environment. Anal. Bioanal. Chem. 387, 1141-1142. (Pubitemid 46220397)
12. Radjenović, J., Petrović, M., and Barceló, D. (2007). Advanced mass spectro-metric methods applied to the study of fate and removal of pharmaceuticals in wastewater treatment. Trac-Trends Anal. Chem. 26, 1132-1144.
13. Huber, M. M., Göbel, A., Joss, A., Hermann, N., Löffler, D., McArdell, C. S., Ried, A., Siegrist, H., Ternes, T. A., and Von Gunten, U. (2005). Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: A pilot study. Environ. Sci. Technol. 39, 4290-4299.
14. Andreozzi, R., Caprio, V., Insola, A., and Marotta, R. (1999). Advanced oxidation processes (AOP) for water purification and recovery. Catal. Today 53, 51-59.
15. Ikehata, K., Naghashkar, N. J., and El-Din, M. G. (2006). Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: A review. Ozone-Sci. Eng. 25, 353-414.
16. Belgiorno, V., Rizzo, L., Fatta, D., Della Rocca, C. D., Lofrano, G., Nikolaou, A., Naddeo, V., and Meric, S. (2007). Review on endocrine disrupting-emerging compounds in urban wastewater: Occurrence and removal by photocataly-sis and ultrasonic irradiation for wastewater reuse. Desalination 215, 166-176.
17. Esplugas, S., Bila, D. M., Krause, L. G. T., and Dezotti, M. (2007). Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. J.Hazard. Mater. 149, 631-642.
18. Ning, B., Graham, N., Zhang, Y., Nakonechny, M., and El-Din, M. G. (2007
19. 2 materials- determination of intermediates and reaction pathways. Water Res. 38, 955-964.
20. Jones, O. A., Green, P. G., Voulvoulis, N., and Lester, J. N. (2007). Questioning the excessive use of advanced treatment to remove organic micropollutants from wastewater. Environ. Sci. Technol. 41, 5085-5089.
21. 2 treatment of antiepileptic drug carbamazepine. Chemosphere 54, 497-505.
22. Barceló, D., and Petrovic, M. (2007). Challenges and achievements of LC-MS in environmental analysis: 25 years on. Trac-Trends Anal. Chem. 26, 2-11.
23. D́az-Cruz, L. S., and Barceló, D. (2006). Determination of antimicrobial residues and metabolites in the aquatic environment by liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem. 386, 973-985.
24. Hao, C., Clement, R., and Yang, P. (2007). Liquid chromatography- tandem mass spectrometry of bioactive pharmaceutical compounds in the aquatic environment- a decade's activities. Anal. Bioanal. Chem. 387, 1247-1257.
25. Hao, C., Zhao, X., and Yang, P. (2007). GC-MS and HPLC-MS analysis of bioac-tive pharmaceuticals and personal-care products in environmental matrices. Trac-Trends Anal. Chem. 26, 569-580.
26. Hernández, F., Sancho, J. V., Ibáñez, M., and Guerrero, C. (2007). Antibiotic residue determination in environmental waters by LC-MS. Trac-Trends Anal. Chem. 26, 466-485.
27. Kosjek, T., Heath, E., Petrović, M., and Barceló, D. (2007). Mass spectrometry for identifying pharmaceutical biotransformation products in the environment. Trac-Trends Anal. Chem. 26, 1076-1085.
28. Pérez, S., and Barceló, D. (2007). Application of advanced MS techniques to analysis and identification of human and microbial metabolites of pharmaceuticals in the aquatic environment. Trac-Trends Anal. Chem. 26, 494-514.
29. Petrovic, M., and Barceló, D. (2007). LC-MS for identifying photodegradation products of pharmaceuticals in the environment. Trac-Trends Anal. Chem. 26, 486-493. (Pubitemid 46891087)
30. Petrović, M., and Barceló, D. (2006). Liquid chromatography- mass spectrom-etry in the analysis of emerging environmental contaminants. Anal. Bioanal. Chem. 385, 422-424.
31. Petrović, M., Gonzalez, S., and Barceló, D. (2003). Analysis and removal of emerging contaminants in wastewater and drinking water. Trac-Trends Anal. Chem. 22, 685-696.
32. Petrović, M., Hernando, M. D., D́az-Cruz, S., and Barceló, D. (2005). Liquid chromatography -tandem mass spectrometry for the analysis of pharmaceutical residues in environmental samples: A review. J. Chromatogr. A 1067, 1-14.
33. Richardson, S. D. (2006). Environmental mass spectrometry: Emerging contaminants and current issues. Anal. Chem. 78, 4021-4045, 2006.
34. Calza, P., Medana, C., Baiocchi, C., and Pelizzetti, E. (2005). Identification of degradation products by adopting GC or HPLC/MS techniques. Curr. Anal. Chem. 3, 267-288.
35. European Commission. (2002). Decision (2002/657/EC) of 12 August 2002 Implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal of the European Communities L221 8-36.
36. Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C., et al. (2007). Chemical Analysis Working Group (CAWG) Metabolimics standards initiative (MSI). Proposed minimum reporting standards for chemical analysis (Version 5.1). Metabolomics 3, 211-221.
37. Doll, T. E., and Frimmel, F. H. (2005). Removal of selected persistent organic pollutants by heterogeneous photocatalysis in water. Catal. Today 101, 195-202.
38. 2/UV system. Water Res. 37, 993-1004.
39. 2. Appl. Catal. B-Environ. 74, 233-241.
40. Andreozzi, R., Canterino, M., Marotta, R., and Paxeus, N. (2005). Antibiotic removal from wastewater: the ozonation of amoxicillin. J.Hazard. Mater. 122, 243-250.
41. Andreozzi, R., Marotta, R., Pinto, G., and Pollio, A. (2002). Carbamazepine in water: Persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Res. 36, 2869-2877.
42. Dantas, R. F., Canterino, M., Marotta, R., Sans, C., Esplugas, S., and Andreozzi, R. (2007). Bezafibrate removal by means of ozonation: Primary intermediates, kinetics, and toxicity assessment. Water Res. 41, 2525-2532.
43. Dantas, R. F., Contreras, S., Sans, C., and Esplugas, S. (2008). Sulfamethoxazole abatement by means of ozonation. J.Hazard. Mater. 150, 790-794.
44. Hartmann, J., Bartels, P., Mau, U., Witter, M., Tümpling, W. V., Hofmann, J., and Nietzschmann, E. (2008). Degradation of the drug diclofenac in water by sonolysis in presence of catalysts. Chemosphere 70, 453-461.
45. 2 photocatalysis. Water Res. 41, 2612-2626.
46. Irmark, S., Erbatur, O., and Akgerman, A. (2005). Degradation of 17β-estradiol and bisphenol A in aqueous medium by using ozone and ozone/UV techniques. J.Hazard. Mater. 126, 54-62.
47. Lange, F., Cornelissen, S., Kubac, D., Sein, M. M., Von Sonntag, J., Hannich, C. B., Golloch, A. B., Heipieper, H. J., Möder, M., and Von Sonntag, C. (2006). Degradation of macrolide antibiotics by ozone: A mechanistic case study with clarithromycin. Chemosphere 65, 17-23.
48. 2 and simulated solar irradiation. Water Res. 42, 585-594.
49. 2 photocatalysis of fluoroquinolone antibacterial agents. Environ. Sci. Technol. 41, 4720-4727.
50. Sirés, I., Arias, C., Cabot, P. L., Centellas, F., Garrido, J. A., Rodŕguez, R. M., and Brillas, E. (2007). Degradation of clofibric acid in acidic aqueous medium by electro-Fenton and photoelectron-Fenton. Chemosphere 66, 1660-1669.
51. 2+ and UVA light as catalysts. Appl. Catal. B-Environ. 72, 373-381.
52. 2+ and UVA light. Appl. Catal. B-Environ. 66, 228-240.
53. 15N-aided inventory of nitrogenous breakdown products. J. Org. Chem. 67, 6143-6151.
54. 2 and ozone. Water Res. 38, 414-422.
55. Huber, M. M., Ternes, T. A., and Von Gunten, U. (2004). Removal of estro-genic activity and formation of oxidation products during ozonation of 17α-ethinylestradiol. Environ. Sci. technol. 38, 5177-5186.
56. Bila, D., Montalvão, A. F., Azevedo, D., and Dezotti, M. (2007). Estrogenic activity removal of 17β-estradiol by ozonation and identification of by-products. Chemosphere 69, 736-746.
57. De Witte, B., Dewulf, J., Demeestere, K., Van De Vyvere, V., De Wispelaere, P., and Van Langenhove, H. (2008). Ozonation of ciprofloxacin in water: HRMS identification of reaction products and pathways. Environ. Sci. Technol. 48, 4889-4995.
58. Gebhardt, W., and Schröder, H. F. (2007). Liquid chromatography (tandem) mass spectrometry for the follow-up of the elimination of persistent pharmaceuticals during wastewater treatment applying biological wastewater treatment and advanced oxidation. J. Chromatogr. A 1160, 34-43.
59. 2 aqueous suspensions by liquid and gas chromatography. J. Chromatogr. A 1183, 38-48.
60. Liu, J., Carr, S., Rinaldi, K., and Chandler, W. (2005). Screening estrogenic oxidized by-products by combining ER binding and ultrafiltration. Environ. Toxicol. Phar. 20, 269-278.
61. 2 photocatalysis as a means of reducing estrogenic activity. Environ. Sci. Technol. 36, 4175-4181.
62. Pérez-Estrada, L. A., Malato, S., Gernjak, W., Agüera, A., Thurman, E. M., Ferrer, I., and Fernández-Alba, A. R. (2005). Photo-Fenton degradation of diclofenac: identification of main intermediates and degradation pathway. Environ. Sci. Technol. 39, 8300-8306.
63. Pérez-Estrada, L. A., Malato, S., Agüera, A., and Fernández, A. R. (2007). Degradation of dipyrone and its main intermediates by solar AOPs Identification of intermediate products and toxicity assessment. Catal. Today 129, 207-214.
64. Zhang, X., Chen, P., Wu, F., Deng, N., Liu, J., and Fang, T. (2006). Degradation of 17α-ethinylestradiol in aqueous solution by ozonation. J.Hazard. Mater. 133, 291-298.
65. Zhao, Y., Hu, J., and Jin, W. (2008). Transformation of oxidation products and reduction of estrogenic activity of 17β-estradiol by a heterogeneous photo-fenton reaction. Environ. Sci. Technol. 42, 5277-5284.
66. Bailac, S., Ballesteros, O., Jiménez-Lozano, E., Barrón, D., Sanz-Nebot, V., Navalón, V., Lchez, J. L., and Barbosa, J. (2004). Determination of quinolones in chicken tissues by liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. A 1029, 145-151.
67. 2. Appl. Catal. B-Environ. 70, 447-451.
68. Hyötyläinen, T., and Riekkola, M.-L. (2008). Sorbent- and liquid-phase microex-traction techniques and membrane-assisted extraction in combination with gas chromatographic analysis: A review. Anal. Chim. Acta 614, 27-37.
69. Palominos, R., Freer, J., Mondaca, M. A., and Mansilla, H. D. (2008). Evidence for hole participation during the photocatalytic oxidation of the antibiotic flume-quine. J. Photochem. Photobiol. A-Chem. 193, 139-145.
70. 2: an efficient photocatalyst for the degradation of aquatic steroid estrogens under natural light irradiation. Environ. Sci. Technol. 41, 3747-3751.
71. McDowell, D. C., Huber, M. M., Wagner, M., Von Gunten, U., and Ternes, T. A. (2005). Ozonation of carbamazepine in drinking water: Identification and kinetic study of major oxidation products. Environ. Sci. Technol. 39, 8014-8022.
72. 2/UV system in aqueous medium. Product identification by gas-chromatography-mass spectrometry (GC-MS). J. Braz. Chem. Soc. 19, 81-88.
73. Seitz, W., Jiang, J. Q., Schulz, W., Weber, W. H., Maier, D., and Maier, M. (2008). Formation of oxidation by-products of the iodinated X-ray contrast medium iomeprol during ozonation. Chemosphere 70, 1238-1246.
74. Barron, E., Deborde, M., Rabouan, S., Mazellie, P., and Legube, B. (2006). Kinetic and mechanistic investigations of progesterone reaction with ozone. Water Res. 40, 2181-2189.
75. 2 suspensions. Appl. Catal. B-Environ. 67, 197-205.
76. Dalmázio I., Almeida, M. O., Augusti, R., and Alves, T. M. A. (2007). Monitoring the degradation of tetracycline by ozone in aqueous medium via atmospheric pressure ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 18, 679-687.
77. Addamo, M., Augugliaro, V., Di Paola, A., Gaŕa-López, Loddo, V., Marc̀, G., and Palmisano, L. (2005). Removal of drugs in aqueous systems by photoassisted degradation. J. Appl. Electrochem. 35, 765-774.
78. Niessen, W. M. A. (1999). Liquid chromatography mass spectrometry (2nd ed). Marcel Dekker, New York.
79. Andreozzi, R., Canterino, M., Lo Giudice, R., Marotta, R., Pinto, G., and Pollio, A. (2006). Lincomycin solar photodegradation, algal toxicity and removal from wastewater by means of ozonation. Water Res. 40, 630-638.
80. Calza, P., Pazzi, M., Medana, C., Baiocchi, C., and Pelizetti, E. (2004). The photocatalytical process as a tool to identify metabolic products formed from dopant substances: the case of buspirone. J. Pharm. Biomed. Anal. 35, 9-19.
81. Calza, P., Medana, C., Pazzi, M., Baiocchi, C., and Pelizetti, E. (2004). Photo-catalytic transformations of sulphonamides on titanium dioxide. Appl. Catal. B-Environ. 53, 63-69.
82. 2 surface by high-performance liquid chromatography/high-resolution mass spectrometry. Rapid Commun. Mass Spectrom. 22, 301-313.
83. Thurman, E. M., and Ferrer, I. (2003). Comparison of quadrupole time-of-flight, triple quadrupole and ion-trap mass spectrometry/mass spectrometry for the analysis of emerging contaminants. American Chemical Society Symposium 850, 14-31.
84. De Witte, B., Dewulf, J., Demeestere, K., and Van Langenhove, H. (2009). Ozonation and advanced oxidation by the peroxone process of ciprofloxacin in water. J.Hazard. Mater. 161, 701-708.
85. Sakkas, V. A., Calza, P., Medana, C., Villioti, A. E., Baiocchi, C., Pelizetti, E., and Albanis, T. (2007). Heterogeneous photocatalytic degradation of the pharmaceutical agent salbutamol in aquoues titanium dioxide suspensions. Appl. Catal. B-Environ. 77, 135-144.
86. Webb, K., Bristow, T., Sargent, M., and Stein, B. (2004). Methodology for accurate mass measurements of small molecules: Best practices guide. LGC Limited, Middlesex, England.
87. Pomati, F., Castiglioni, S., Zuccato, E., Fanelli, R., Vigetti, D., Rossetti, C., and Calamari, D. (2006). Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ. Sci. Technol. 40, 2442-2447.
88. Drlica, K. (2003). The mutant window and antimicrobial resistance. J. Antimi-crob. Chemoth. 52, 11-17.